| Health / Medical Topics |
Vaccinia-Tyrosinase Vaccine
A vaccine consisting of recombinant vaccinia virus, based on the modified vaccinia virus Ankara (MVA) that encodes the melanoma-associated antigen tyrosinase. Vaccination with vaccinia-tyrosinase may stimulate the host immune system to mount a cytotoxic T-cell response against tumor cells expressing tyrosinase. Tyrosinase is a melanoma-specific differentiation agent that catalyzes the synthesis of the melanin precursor L-3,4-dihydroxyphenylalanine (L-DOPA). (NCI Thesaurus)
YOU MAY ALSO LIKE
A cancer vaccine made with a form of a vaccinia virus that does not cause disease in humans. It is being studied…
A recombinant vaccinia virus that encodes granulocyte-macrophage colony stimulating factor (GM-CSF). By activating T-cells and macrophages, vaccination with recombinant vaccinia GM-CSF may…
Clinical Vaccinia Virus Studies employ vaccinia virus as an attenuated agent or as a vector for gene transfer. In attenuated form, Vaccinia…
A highly tumor-selective vaccinia virus (vv) with an engineered double deletion (DD) of the thymidine kinase (tk) and vaccinia growth factor genes…
DNA viruses used in several biotechnology applications, including expression vector systems.
A class of antineoplastic vaccines containing the vaccinia virus, originally used for immunization against smallpox, as a viral vector and immunogenic…
